Myeloperoxidase Peptide-Based Nasal Tolerance in Experimental ANCA-Associated GN.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1681/ASN.2015010089PMID 26047792PMCID PMC4731124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN.

  2013cited by this paper
• KDOQI US commentary on the 2012 KDIGO clinical practice guideline for glomerulonephritis.

  2013cited by this paper
• Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.

  2013cited by this paper
• The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis

  2012cited by this paper
• Notice

  2012cited by this paper
• Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis.

  2012cited by this paper
• Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis.

  2010cited by this paper
• Immunopathology and Infectious Diseases Mucosal Tolerance Induced by an Immunodominant Peptide from Rat 3 ( IV ) NC 1 in Established Experimental Autoimmune Glomerulonephritis

  2010cited by this paper
• Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.

  2009cited by this paper
• Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.

  2007cited by this paper
• Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

  2007cited by this paper
• Myeloperoxidase: friend and foe

  2005cited by this paper
• Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.

  2005cited by this paper
• Constraints on the Efficacy of Mucosal Tolerance in Treatment of Human and Animal Arthritic Diseases

  2004cited by this paper
• Current Issues in the Treatment of Human Diseases by Mucosal Tolerance

  2004cited by this paper
• Prevention of mucosally induced uveitis with a HSP60‐derived peptide linked to cholera toxin B subunit

  2003cited by this paper
• Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells.

  2003cited by this paper
• Nasal administration of CTB‐insulin induces active tolerance against autoimmune diabetes in non‐obese diabetic (NOD) mice

  2002cited by this paper
• Risk of ovarian failure and fertility after intravenous cyclophosphamide. A study in 84 patients.

  2002cited by this paper
• Total dose and frequency of administration critically affect success of nasal mucosal tolerance induction

  2001cited by this paper
• Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.

  2000cited by this paper
• Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis.

  2000cited by this paper
• Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.

  1999cited by this paper
• Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.

  1998cited by this paper
• Dose‐dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats

  1998cited by this paper
• Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma.

  1998cited by this paper
• Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases.

  1997cited by this paper
• Suppression of murine collagen‐induced arthritis by nasal administration of collagen

  1997cited by this paper
• A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

  1997cited by this paper
• Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

  1996cited by this paper
• Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus.

  1996cited by this paper
• Effects of cyclophosphamide on the development of malignancy and on long-term survival of patients with rheumatoid arthritis. A 20-year followup study.

  1995cited by this paper

• Can we cure vasculitis?

  2025cites this paper
• Tr1 Cells Emerge and Suppress Effector Th17 Cells in Glomerulonephritis.

  2023cites this paper
• Emergence and suppressive function of Tr1 cells in glomerulonephritis

  2023cites this paper
• Mechanisms of vascular damage in ANCA vasculitis

  2022cites this paper
• Anti-CD20 mAb-Induced B Cell Apoptosis Generates T Cell Regulation of Experimental Myeloperoxidase ANCA-Associated Vasculitis

  2021cites this paper
• Animal Models of ANCA Associated Vasculitis

  2020cites this paper
• Podocytes present antigen to activate specific T cell immune responses in inflammatory renal disease

  2020cites this paper
• Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.

  2020influential citation
• Apoptotic Cell-Induced, Antigen-Specific Immunoregulation to Treat Experimental Antimyeloperoxidase GN.

  2019cites this paper
• T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach

  2019cites this paper
• Biologicals targeting T helper cell subset differentiating cytokines are effective in the treatment of murine anti-myeloperoxidase glomerulonephritis.

  2019cites this paper
• Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis.

  2019cites this paper
• Regulatory T cells in renal disease

  2018cites this paper
• CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN.

  2017cites this paper
• Disentangling the role of neutrophil extracellular traps in rheumatic diseases.

  2017cites this paper
• ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing.

  2017cites this paper
• New therapeutic approaches for ANCA-associated vasculitides.

  2016cites this paper
• Immune Response against Autoantigen PLA2R Is not Gambling: Implications for Pathophysiology, Prognosis, and Therapy.

  2016cites this paper
• Overview of the Pathogenesis of ANCA-Associated Vasculitis

  2015cites this paper